|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
����� |
|
�����Ʒ� |
|
ϸ������ |
| ��������������� | |
|
���� |
|
���� |
| PubMed | |
|
Article by |
|
Article by |
ϵͳ�����������������
����, ����
�й�ҽѧ��ѧԺ���й�Э��ҽ�ƴ�ѧƤ�����о���, �Ͼ� 210042
ϵͳ��������ķ�������������,�����кܸߵ�������,��Ŀǰ��Ч�������ֶ�ȴ������,��������ʾ�����ҩ����Ӧ��ϸ�����ӽ������������ѳ�Ϊ����ϵͳ�����������ǰ;���ֶ�,��������ϸ�����ӵ������⿹������ü����ٴ�Ӧ��.
[2] Kudeken N, Kawakami K, Saito A. Cytokine-induced fungicidal activity of human polymorphonuclear leukocytes against Penicillium marneffei. FEMS Immunol Med Microbiol, 1999, 26:115-124.
[3] Gaviria JM, van Burik JA, Dale DC, et al. Comparison of interferongamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens. J Infect Dis, 1999, 179:1038-1041.
[4] Kurita N, Oarada M, Ito E,et al. Antifungal activity of human polymorphonuclear leucocytes against yeast cells of Paracoccidioides brasiliensis. Med Mycol, 1999, 37:261-267.
[5] Kurita N, Biswas SK, Oarada M, et al. Fungistatic and fungicidal activities of murine polymorphonuclear leucocytes against yeast cells of Paracoccidioides brasiliensis. Med Mycol, 1999, 37:19-24.
[6] Vazquez N, Walsh TJ, Friedman D, et al. Interleukin15 augments superoxide production and microbicidal activity of human monocytes against Candida albicans. Infect Immun, 1998, 66:145-150.
[7] Roilides E, Kadiltsoglou I, Dimitriadou A, et al. Interleukin-4 suppresses antifungal activity of human mononuclear phagocytes against Candida albicans in association with decreased uptake of blastoconidia. FEMS Immunol Med Microbiol, 1997, 19:169-180
[8] Roilides E, Katsifa H, Tsaparidou S, et al. Interleukin 10 suppresses phagocytic and antihyphal activities of human neutrophils. Cytokine,2000, 12:379-387.
[9] Kullberg BJ, Netea MG, Curfs JH,et al. Recombinant murine granu1ocyte colony-stimulating factor protects against acute disseminated Candida albicans infection in nonneutropenic mice. J Infect Dis,1998, 177:175-181.
[10] Mayer P, Schutze E, Lam C, et al. Recombinant murine granulocytemacrophage colony-stimulating factor augments neutrophil recovery and enhances resistance to infections in myelosuppressed mice. J Infect Dis, 1991, 163:584-590.
[11] Cenci E, Bartocci A, Puccetti P, et al. Macrophage colony-stimulating factor in murine candidiasis:serum and tissue levels during infection and protective effect of exogenous administration. Infect Immun,1991, 59:868-872.
[12] Gonzalez CE, Lyman CA, Lee S, et al. Recombinant human macrophage colony-stimulating factor augments pulmonary host defences against Aspergillus fumigatus. Cytokine, 2001, 15:87-95.
[13] Schelenz S, Smith DA, Bancroft GJ. Cytokine and chemokine responses following pulmonary challenge with Aspergillus fumigatus:obligatory role of TNF-alpha and GM-CSF in neutrophil recruitment. Med Mycol, 1999, 37:183-194.
[14] Mencacci A, Perruccio K, Bacci A, et al. Defective antifungal Thelper 1(TH1)immunity in a murine model of allogeneic T-cell-depleted bone marrow transplantation and its restoration by treatment with TH2 cytokine antagonists. Blood, 2001, 97:1483-1490.
[15] Kawakami K, Hossain Qureshi M, Zhang T, et al. Interleukin-4 weakens host resistance to pulmonary and disseminated cryptococcal infection caused by combined treatment with interferon-gamma-inducing cytokines. Cell Immunol, 1999, 197:55-61.
[16] Clemons KV, Darbonne WC, Curnutte JT, et al. Experimental histoplasmosis in mice treated with anti-murine interferon-gamma antibody and in interferon-gamma gene knockout mice. Microbes Infect, 2000,2:997-1001.
[17] Clemons KV, Lutz JE, Stevens DA. Efficacy of interferon-gamma and amphotericin B for the treatment of systemic murine histoplasmosis.Microbes Infect, 2001, 3:3-10.
[18] Gaviria JM, van Burik JA, Dale DC, et al. Modulation of neutrophilmediated activity against the pseudohyphal form of Candida albicans by granulocyte colony-stimulating factor(G-CSF)administered in vivo. J Infect Dis, 1999, 179:1301-1304.
[19] Dorman SE, Guide SV, Conville PS, et al. Nocardia infection in chronic granulomatous disease. Clin Infect Dis, 2002, 35:390.
[20] Flynn TN, Kelsey SM, Hazel DL,et al. Cost effectiveness of amphotericin B plus G-CSF compared with amphotericin B monotherapy.Treatment of presumed deep-seated fungal infection in neutropenic patients in the UK. Pharmacoeconomics, 1999, 16:543-550.